Novel method for preventing or treating M tuberculosis infection

Details for Australian Patent Application No. 2006243357 (hide)

Owner GlaxoSmithKline Biologicals S.A. Infectious Disease Research Institute (IDRI)

Inventors Lobet, Yves; Coler, Rhea; Reed, Steven

Agent Shelston IP

Pub. Number AU-B-2006243357

PCT Pub. Number WO2006/117240

Priority 60/777,017 27.02.06 US; 60/676,549 29.04.05 US

Filing date 27 April 2006

Wipo publication date 9 November 2006

Acceptance publication date 15 March 2012

International Classifications

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/117240 Priority application(s): WO2006/117240

15 March 2012 Application Accepted

  Published as AU-B-2006243357

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243358-Polypeptide, vaccine and use thereof

2006243352-Compartmentalized resin pellets for oxygen scavenging